World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
70
Citations
19307
World Ranking
20076
National Ranking
9998

Overview

Robert M. Hamer was affiliated with the University of North Carolina at Chapel Hill in the United States. Their primary research contributions were within the field of Medicine, with significant work in Clinical Psychology, Pediatrics, Perinatology and Child Health, Psychiatry and Mental Health, Public Health, Environmental and Occupational Health, and Endocrinology, Diabetes and Metabolism.

The scientist's research topics included Eating Disorders and Behaviors, Schizophrenia Research and Treatment, Birth, Development, and Health, Diet and Metabolism Studies, Neuroendocrine Regulation and Behavior, Child and Adolescent Psychosocial and Emotional Development, and Health Systems, Economic Evaluations, and Quality of Life.

Frequent coauthors collaborating with Robert M. Hamer included:

  • Cynthia M. Bulik
  • John H. Gilmore
  • Sandra Woolson
  • Rebecca Knickmeyer
  • Martin Styner

The scientist's published research appeared predominantly in UNC Libraries, along with contributions to World Psychiatry, Contemporary Clinical Trials, and Clinical Neurophysiology.

Selected recent papers reflected diverse topics and research areas:

  • Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial (2020, World Psychiatry)
  • Rationale, design, and methods of the Autism Centers of Excellence (ACE) network Study of Oxytocin in Autism to improve Reciprocal Social Behaviors (SOARS-B) (2020, Contemporary Clinical Trials)
  • Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia: A Randomized Clinical Trial (2020, UNC Libraries)
  • Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood (2020, UNC Libraries)
  • Event related potentials indexing the influence of emotion on cognitive processing in veterans with comorbid post-traumatic stress disorder and traumatic brain injury (2021, Clinical Neurophysiology)

Best Publications

  • A Structural MRI Study of Human Brain Development from Birth to 2 Years

    Rebecca C. Knickmeyer;Sylvain Gouttard;Chaeryon Kang;Dianne Evans

  • The Cook-Medley hostility scale: item content and ability to predict survival.

    J C Barefoot;K A Dodge;B L Peterson;W G Dahlstrom

  • Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study

    Linmarie Sikich;Jean A. Frazier;Jon McClellan;Robert L. Findling

  • Regional Gray Matter Growth, Sexual Dimorphism, and Cerebral Asymmetry in the Neonatal Brain

    John H. Gilmore;Weili Lin;Marcel W. Prastawa;Christopher B. Looney

  • Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol

    Jeffrey A. Lieberman;Gary Tollefson;Mauricio Tohen;Alan I. Green

  • Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

    Joseph P. McEvoy;Jeffrey A. Lieberman;M.P.H. Diana O. Perkins;Robert M. Hamer

  • Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine

    Jeffrey A Lieberman;Michael Phillips;Hongbin Gu;Scott Stroup

  • Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol

    Richard S E Keefe;Larry J Seidman;Bruce K Christensen;Robert M Hamer

  • A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial

    Linmarie Sikich;Robert M Hamer;Robert A Bashford;Brian B Sheitman;Brian B Sheitman

  • Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

    Richard S.E. Keefe;John A. Sweeney;Hongbin Gu;Robert M. Hamer

  • Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.

    R Grant Steen;Robert M Hamer;Jeffrey A Lieberman

  • An emotional component analysis of chronic pain.

    James B. Wade;Donald D. Price;Robert M. Hamer;Steven M. Schwartz

  • First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.

    Alan I Green;Alan I Green;Mauricio F Tohen;Robert M Hamer;Stephen M Strakowski

  • Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder : A Randomized, Double-Blind, Flexible-Dose, Multicenter Study

    Diana O. Perkins;Hongbin Gu;Peter J. Weiden;Joseph P. McEvoy

  • Use of Text Messaging for Monitoring Sugar-sweetened Beverages, Physical Activity, and Screen Time in Children: A Pilot Study

    Jennifer R. Shapiro;Stephanie Bauer;Robert M. Hamer;Hans Kordy

  • Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood.

    L.A. Glantz;J.H. Gilmore;R.M. Hamer;J.A. Lieberman

  • Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials

    Robert M. Hamer;Pippa M. Simpson

  • Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury

    Marca L Sipski;Raymond C Rosen;Craig J Alexander;Robert M Hamer

  • Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia.

    Christine E. Marx;Christine E. Marx;Richard S.E. Keefe;Robert W. Buchanan;Robert M Hamer

  • Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.

    Diana O. Perkins;Jacqueline L. Johnson;Robert M. Hamer;Robert B. Zipursky

Frequent Co-Authors

Donald D. Price
Donald D. Price University of Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in Medicine, it's worth exploring related online degrees and alternative career pathways within healthcare. Many professionals choose to pursue an online health management degree to gain foundational skills in managing hospital departments, medical practice groups, or even entire health systems.

For those seeking advanced leadership roles, the cheapest online mha programs can provide a cost-effective path to earning a master's degree in healthcare administration. This qualification is highly valued for executive and administrative careers in healthcare organizations.

Nurses looking to take on clinical leadership or advanced practice roles often opt for the most affordable online dnp programs, which are designed for working professionals seeking a Doctor of Nursing Practice.

Additionally, those interested in pharmacy fields can consider online pharmacy school programs, which open doors to research, pharmaceutical careers, and clinical practice.

Exploring these online programs can provide greater flexibility and affordability, helping you find the right fit for your future in healthcare.

Best Scientists Citing Robert M. Hamer

Recently Published Articles